(PDF) The Beneficial Effects of Empagliflozin, an SGLT2

The Beneficial Effects of Empagliflozin, an SGLT2 Inhibitor, on Atherosclerosis in ApoE −/− Mice Fed a Western Diet

Diabetologia - Germany

doi 10.1007/s00125-016-4158-2

Full Text

Abstract

Available in full text

Categories

Internal Medicine

Date

November 19, 2016

Authors

Publisher

Springer Science and Business Media LLC

Related search

Nur77 Decreases Atherosclerosis Progression in apoE−/− Mice Fed a High-Fat/High-Cholesterol Diet

Multidisciplinary

English

The Enhanced Expression of IL-17-secreting T Cells During the Early Progression of Atherosclerosis in ApoE-deficient Mice Fed on a Western-Type Diet

Experimental & Molecular Medicine

English

Fenretinide Treatment Accelerates Atherosclerosis Development in apoE‐deficient Mice in Spite of Beneficial Metabolic Effects

British Journal of Pharmacology

English

Absence of Microbiota (Germ-Free Conditions) Accelerates the Atherosclerosis in ApoE-Deficient Mice Fed Standard Low Cholesterol Diet

Journal of Atherosclerosis and Thrombosis

Internal Medicine

Cardiovascular Medicine

English

Trimethylamine N-Oxide Supplementation Abolishes the Cardioprotective Effects of Voluntary Exercise in Mice Fed a Western Diet

Frontiers in Physiology

English

Hepatocyte Sortilin 1 Knockout and Treatment With a Sortilin 1 Inhibitor Reduced Plasma Cholesterol in Western Diet-Fed Mice

Journal of Lipid Research

English

Deficiency of PXR Decreases Atherosclerosis in apoE-deficient Mice

Journal of Lipid Research

English

Empagliflozin: A New Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Drugs in Context

Molecular Medicine

English

Probiotic Mixture VSL#3 Reduce High Fat Diet Induced Vascular Inflammation and Atherosclerosis in ApoE−/− Mice

Applied Microbiology

English